Infective endocarditis in adults.
Mylonakis
E
E
Division of Infectious Diseases, Massachusetts General Hospital, Boston 02114, USA.
Calderwood
S B
SB
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis; D002493:Central Nervous System Diseases / Q000209:etiology; D003131:Combined Modality Therapy; D004452:Echocardiography; D004696:Endocarditis / Q000175:diagnosis / Q000382:microbiology / Q000401:mortality / Q000628:therapy; D004697:Endocarditis, Bacterial / Q000150:complications / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D006333:Heart Failure / Q000209:etiology; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D008826:Microbial Sensitivity Tests; D009181:Mycoses / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000382:microbiology / Q000628:therapy; D012008:Recurrence; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000382:microbiology; D013290:Streptococcal Infections / Q000175:diagnosis / Q000382:microbiology
D000890:Anti-Infective Agents